AAV13 vector system (AAV13 expression system, AAV13 packaging plasmid system) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV13 Vector system is including: 1) AAV13 Rep-Cap plasmid (AAV13-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV13 particle in 293T cell line in high titer using GeneMedi's AAV13 Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV13 vector has been validated in muscle, liver, and lung with high transduction efficiency, showing potential applications in metabolic and respiratory gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | First Order Discount | First Order Discount Price |
|---|---|---|---|---|---|
| P-PK45 | AAV13 Vector System (Amp resistance) 1. AAV13 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3379 | 50% | 1689.5 |
| P-PK45 | AAV13 Vector System (Amp resistance) 1. AAV13 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-PK45 | AAV13 Vector System (Amp resistance) 1. AAV13 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-PK45 | AAV13 Vector System (Amp resistance) 1. AAV13 Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK45-Kan | AAV13 Vector System (Kan resistance) 1. AAV13 Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC45 | AAV13 Rep-Cap
Plasmid (Amp resistance)
Size:5ug |
Academic | 2062 | 50% | 1031 |
| P-RC45 | AAV13 Rep-Cap
Plasmid (Amp resistance)
Size:5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-RC45 | AAV13 Rep-Cap
Plasmid (Amp resistance)
Size:5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-RC45 | AAV13 Rep-Cap
Plasmid (Amp resistance)
Size:≥10mg |
All | |||
| P-RC45-Kan | AAV13 Rep-Cap
Plasmid(Kan resistance)
Size:≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
No data available.
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
| PurProX™ AAVEasy rapid-to-purify Spin Column | Detail |


Go to AAV
vector system
>>